final results of the randomised phase ii norcap-ca223 trial comparing first-line all-oral versus taxane-based chemotherapy for her2-negative metastatic breast cancer
本文档由 qir772361 分享于2017-04-22 02:15
final results of the randomised phase ii norcap-ca223 trial comparing first-line all-oral versus taxane-based chemotherapy for her2-negative metastatic breast cancer
下载文档
收藏
打印
分享：
君，已阅读到文档的结尾了呢~~